Amgen Wins Ruling on Patents for Kyprolis Cancer Drug

(Bloomberg) -- Amgen Inc. won a federal court ruling in a patent infringement lawsuit that could keep its Kyprolis injectable cancer treatment free from generic competition until the last of the pa...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.